Interventional strategies for inferior phrenic artery management in yttrium‑90 selective internal radiation therapy for hepatocellular carcinoma: A single‑center retrospective study
European Journal of Nuclear Medicine and Molecular Imaging · 2026-11 · 53 (13) · 8630-8639
DOI: 10.1007/s00259-026-08170-0 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Nuclear Medicine and Molecular Imaging, online erschienen am 18.09.2026. Verfasst von Yong Liao und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua Uni…. Hauptthemen laut MEDLINE: Yttrium Radioisotopes, Carcinoma, Hepatocellular, Liver Neoplasms, Arteries. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).
Abstract (Originalsprache)
OBJECTIVE: Extrahepatic collateral supply from the inferior phrenic artery (IPA) is frequently observed in patients with hepatocellular carcinoma (HCC) undergoing yttrium-90 selective internal radiation therapy (90Y-SIRT). Currently, no standardized IPA management algorithm has been established. This study aimed to propose stratified interventional strategies for IPA and compare the safety and oncological outcomes between two mainstream approaches. METHODS: A retrospective analysis was performed on 290 consecutive unresectable HCC patients treated with 90Y-SIRT between October 2022 and December 2025. Patients with suspected IPA tumor perfusion on pre-treatment cross-sectional imaging were enrolled. All patients underwent superselective IPA catheterization under combined digital subtraction angiography (DSA) and cone-beam computed tomography (CBCT). According to tumor volume and anatomical characteristics of non-target vessels, patients were divided into direct Y-90 infusion group and IPA embolization group. Tumor response and treatment-related adverse events were assessed and compared. RESULTS: A total of 78 patients with angiographically confirmed IPA tumor supply were finally enrolled, including 45 patients in the IPA Y-90 infusion group and 33 in the IPA embolization group. The median administered radioactivity via IPA was 0.3 GBq. Based on modified Response Evaluation Criteria in Solid Tumors (mRECIST), the objective response rates (ORRs) at 1 and 3 months were 60.0% and 82.3% in the infusion group, versus 48.5% and 69.7% in the embolization group. The compensatory distribution rate of Y-90 microspheres in the original IPA-perfused regions reached approximately 88.0% after IPA embolization. Only mild, reversible thoracic adverse events were noted in both groups, with no severe treatment-related complications. CONCLUSION: DSA-CBCT combined evaluation is essential for pre-procedural IPA anatomical assessment. Direct Y-90 microsphere infusion via IPA yields superior tumor control when non-target vessels are manageable and IPA-perfused tumor volume ≥ 20 mL. IPA embolization is a reliable alternative for patients with untreatable non-target branches or tumor volume < 20 mL. Both strategies demonstrate favorable safety profiles. The proposed stratified algorithm represents a preliminary approach that warrants further external validation for IPA management during 90Y-SIRT for HCC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Hepatobiliary and Pancreatic Surgery, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102200, P.…
- Department of Hepatobiliary Intervention, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, No. 168 Litang Road, Changping District, Beijing, 102200, P. R. China.
- Yttrium-90 Precision Interventional Radiotherapy Center, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
- Precise Intervention-Radiotherapy Research Center, School of Clinical Medicine, Tsinghua University, Beijing, 102200, P. R. China.
- Department of Nuclear Medicine, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
- Department of Radiology, Beijing Tsinghua Changgung Hospital, School of Clinical Medicine, Tsinghua Medicine, Tsinghua University, Beijing, 102200, P. R. China.
Zitieren
APA
Liao, Y., Huang, X., Liang, Z., Ma, J., Feng, X., Fu, W., Liang, B., Yang, S., Li, G., Bao, L., Zhang, T., Zheng, L., Liu, C., Tang, M., Zhang, L., & Dong, J. (2026). Interventional strategies for inferior phrenic artery management in yttrium‑90 selective internal radiation therapy for hepatocellular carcinoma: A single‑center retrospective study. European Journal of Nuclear Medicine and Molecular Imaging, 53(13), 8630-8639. https://doi.org/10.1007/s00259-026-08170-0
Vancouver
Liao Y, Huang X, Liang Z, Ma J, Feng X, Fu W, et al. Interventional strategies for inferior phrenic artery management in yttrium‑90 selective internal radiation therapy for hepatocellular carcinoma: A single‑center retrospective study. European Journal of Nuclear Medicine and Molecular Imaging. 2026;53(13):8630-8639. doi:10.1007/s00259-026-08170-0
BibTeX
@article{Liao2026,
author = {Liao, Yong and Huang, Xin and Liang, Ziwei and Ma, Junpeng and Feng, Xiaobin and Fu, Wenkang and Liang, Bin and Yang, Shizhong and Li, Guangxin and Bao, Lei and Zhang, Tiantian and Zheng, Linxia and Liu, Can and Tang, Mulan and Zhang, Lin and Dong, Jiahong},
title = {Interventional strategies for inferior phrenic artery management in yttrium‑90 selective internal radiation therapy for hepatocellular carcinoma: A single‑center retrospective study},
journal = {European Journal of Nuclear Medicine and Molecular Imaging},
year = {2026},
volume = {53},
number = {13},
pages = {8630--8639},
doi = {10.1007/s00259-026-08170-0}
}
EUVIMED